These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6222203)

  • 1. What is role of factor VIII therapy in inducing helper suppressor ratio reversals in hemophiliacs?
    Hager T
    JAMA; 1983 Jun; 249(24):3277. PubMed ID: 6222203
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased helper-suppressor cell ratios following treatment with blood products: factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV; Lewis JH; Spero JA; Bontempo FA; Rabin BS
    Scand J Haematol Suppl; 1984; 40():371. PubMed ID: 6236552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemophilia and HTLV-III infection].
    Lechler E
    Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
    Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered immune regulation in haemophiliacs not exposed to commercial factor VIII.
    Ludlam CA; Carr R; Veitch SE; Steel CM
    Lancet; 1983 May; 1(8335):1226. PubMed ID: 6134027
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS).
    Landay A; Poon MC; Abo T; Stagno S; Lurie A; Cooper MD
    J Clin Invest; 1983 May; 71(5):1500-4. PubMed ID: 6222070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
    Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological investigation in hemophiliacs with and without human immunodeficiency virus (HIV) infection].
    Pang XG; Tang DJ
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):685-7, 729-30. PubMed ID: 1840032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
    Ludlam CA; Tucker J; Steel CM; Tedder RS; Cheingsong-Popov R; Weiss RA; McClelland DB; Philp I; Prescott RJ
    Lancet; 1985 Aug; 2(8449):233-6. PubMed ID: 2862416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized lymphadenopathy and T cell abnormalities in hemophilia A.
    Gill JC; Menitove JE; Wheeler D; Aster RH; Montgomery RR
    J Pediatr; 1983 Jul; 103(1):18-22. PubMed ID: 6223133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
    Sullivan JL; Brewster FE; Brettler DB; Forsberg AD; Cheeseman SH; Byron KS; Baker SM; Willitts DL; Lew RA; Levine PH
    J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acquired immunodeficiency in a patient with hemophilia].
    Alkan M; Kuperman O; Goldstein G; Berginer V
    Harefuah; 1986 Aug; 111(3-4):74-6. PubMed ID: 3098652
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormality of helper/suppressor T cell ratio in patients with hemophilia.
    Yasuda K; Matsumoto K; Okubo K; Yokoyama MM; Hiyoshi Y; Natori H
    J Clin Lab Immunol; 1985 Jan; 16(1):27-30. PubMed ID: 2984427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma.
    Mannucci PM; Gringeri A; Ammassari M; Mari D
    Am J Hematol; 1984 Aug; 17(2):167-76. PubMed ID: 6235744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia and thrombocytopenia in a patient with impaired cellular immunity. A case report.
    Zeitlhuber U; Haschke F; Püspök R; Lechner K; Knapp W; Imbach P
    Blut; 1984 Jun; 48(6):393-5. PubMed ID: 6234952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.